All Stories

  1. Pulmonary nodules, knowledge renovation and comprehensive studies
  2. Personalized Oncology: Scientific and Technical Approaches
  3. Advances in Cancer Therapeutics and Genomics for Improved Patient Outcomes
  4. Magnetic water and clinical cancer chemotherapy
  5. Human suicide, clinical treatment overview
  6. Sexually transmitted disease diagnosis and treatments, risk factors from beyond
  7. Human suicide, risk factors and new perspective
  8. Suicide study, new approaches
  9. Human suicide, molecular framework
  10. Withdrawn: Professor Bin Xu, A Legendary Pharmacologist in People’s Republic of China
  11. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  12. Anticancer Drug Development, Pharmaceutical Progress
  13. Human Suicide, Biomedical Knowledge Advances
  14. Type 2 Diabetes Treatments in Countries of Different Economic Status
  15. Human suicide, biomedical knowledge and therapeutic advances
  16. Human Suicide, an Overview of Management Strategies
  17. COVID-19 Research, Public Health and Biomedical Basis
  18. Human Suicide, Management Landscape
  19. Anticancer Drug Development: Evaluative Architecture
  20. COVID-19 Study: A New Principle Discovery
  21. COVID-19 Study, Diagnostic and Therapeutic Transition
  22. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  23. Nursery services advances, global campaign
  24. Different approaches to bone transplantation surgery
  25. Bone Metastasis Diagnosis, Blood Biomarker Detections
  26. Anti-metastatic drug development, overview and perspectives
  27. Educational Perspectives for Nursery
  28. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  29. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  30. Suicide Curative Treatment Study and Drug Development
  31. Pulmonary nodules, is there any pathogenesis evidence?
  32. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  33. Pulmonary nodules, surgery or other medication
  34. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  35. Pulmonary Nodules, Surgery or Other Medication
  36. Anti-Metastatic Drug Developments, Utility of More Animal Models
  37. Several approaches for anticancer drug development progress
  38. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  39. COVID-19 infection for metabolic abnormal human beings
  40. Fundamental knowledge for nurses 
  41. Nursery promotion, education and system updating
  42. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  43. Covid-19 Study, Pathology and Therapeutics
  44. Acupuncture for Bone Disease Treatments, Modern Approaches
  45. Cancer Bone Metastasis, Experimental Study
  46. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  47. Osteoporosis Targeting, Possible Breakthroughs
  48. Neuropsychiatric insights for human suicide
  49. Bone Cancer and Metastasis Trials, Drug Treatment
  50. Neurobiology for human suicide
  51. Bone Disease Treatment Study, Major Pathways
  52. Pathology Study for Human Suicide
  53. Nursery activity and quality, chemistry between doctors and nurses
  54. Nursery education, narrow-range or wide-range
  55. Anticancer drug development, challenge and dilemma
  56. Life Origin on Earth, Knowledge Development
  57. HIV/AIDS treatment, therapeutic strategy break throughs
  58. Nursery education for diabetes
  59. Suicide Risks and Prevention, Neuropathogenic Study
  60. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  61. General information for nursery
  62. Historical analysis of suicide
  63. Drug sensitivity testing, a unique drug selection strategy
  64. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  65. Medical treatments for incurable diseases, palliative therapy
  66. Life Origin on Earth, Biochemical Approaches
  67. Nursery training, from technique details in schools into medical knowledge education in nursery career
  68. Herbal medicine in new era
  69. Nursery service, quality promotion
  70. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  71. Patient’s care and nursery in different diseases
  72. Ebola Therapeutic Study and Future Directions
  73. New HIV/AIDS Therapeutics
  74. Nursery Service in Modern Days
  75. Nursery Education, Capability and Service Promotion
  76. Nursery Science and Conventions
  77. Cancer Bioinformatics in Cancer Therapy
  78. Individualized Cancer Therapy
  79. Human Suicide Risk and Treatment Study
  80. Type 2 Diabetes Treatment and Drug Development Study
  81. Hypotheses for Life Origin on Earth, Comparison and Validation
  82. Type 2 Diabetes Study, Introduction and Perspective
  83. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  84. Anthocyanins and its biological & therapeutic characters
  85. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  86. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  87. Pathology and treatments of obesity
  88. Obesity, Risks and Managements
  89. Keep up the pace of drug development evolution and expenditure
  90. An Overview of Obesity
  91. General Topics in the Field of Personalized Cancer Therapy
  92. Human Suicide Risk Study and Treatment: A Mathematical Approach
  93. Anti-Metastatic Drug Developments: Work Out towards New Direction
  94. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  95. Drug Combination in Clinical Cancer Treatments
  96. General outlook for individualized cancer therapy
  97. Ebola origin and treatment
  98. Different Disciplines in the Field of Suicide Study
  99. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  100. HAART in HIV/AIDS Treatments
  101. Anticancer Drug Development, System Updating and Global Participations
  102. Life Origin on Earth, What is the Right Answer?
  103. Life Origin on Earth, What is the Right Answer?
  104. Anticancer Drug Development, Getting out from Bottleneck
  105. Anticancer Drug Development, Getting out from Bottleneck
  106. Human suicide study, major disciplines and treatment outcomes
  107. Anticancer drug development
  108. HIV in Human Genomes and Therapeutics
  109. HIV Biotherapy and Natural Chemotherapeutic Agents
  110. Anticancer Drug Combinations, How Far We can Go Through?
  111. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  112. Life Origin on Earth, Insights among Different Arguments
  113. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  114. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  115. Anticancer Drug Development, Breakthroughs are Waiting
  116. Cancer metastasis treatment, a key drawbacks
  117. The suicide treatment, a new model
  118. HIV Vaccine for Prevention and Cure, A Mission Possible
  119. Zika Therapy
  120. HIV vaccine
  121. Discover Natural Chemical Drugs in Modern Medicines
  122. Mathematics in biomedical science
  123. The origin of HIV
  124. Human suicide study
  125. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  126. Pharmacogenetics of Cancer Therapy
  127. Anticancer Drug Sensitivity Testing
  128. New Perspectives of HIV/AIDS Therapy Study
  129. Antidepressant treatment study
  130. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  131. Assistant cancer treatments in the clinic
  132. Drug sensitivity testing in clinical cancer treatments
  133. Anticancer drug combination in the clinic
  134. Anticancer drug pharmacogenomics in cancer chemotherapy
  135. Cost-effectiveness for personalized cancer therapy
  136. Conclusion
  137. Introduction
  138. Discussion
  139. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  140. Anti-diabetic treatments
  141. Anticancer Drug Combinational Study
  142. The Origins of HIV
  143. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  144. Anticancer Drug Combinations, A Big Momentum is Needed
  145. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  146. Future Perspectives for Controlling Ebola Epidemics
  147. Ebola Origin and Therapies
  148. Cancer Bioinformatics, its Impacts on Cancer Therapy
  149. Copyright
  150. List of figures and tables
  151. Anti-diabetic treatments, patho-therapeutic relation
  152. Origin of Ebola, hypothesis
  153. Personalized Cancer Therapy: A Perspective
  154. Rethink Of Diabetes Treatment and Drug Development
  155. Pharmacogenomics in human suicide prediction and treatments
  156. Cancer metastasis treatment study and drug developments
  157. Challenge for HIV/AIDS therapy
  158. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  159. Drug Combinations in Cancer Treatments
  160. New Insights into Individualized Antimetastatic Therapy
  161. Anticancer drugs on serum sialic acid level in mice bearing LLC
  162. Drug Combinations in Cancer Treatments
  163. Genetics in Neural Toxicity of Drugs
  164. Avian flu, pathogenesis and therapeutic study
  165. First Genetic Information Replication in Life Origin on Earth
  166. Origins of Life, A New Cooperative Model
  167. Cancer Metastases and Clinical Therapies
  168. Origins of Life, RNA world or alternative RNA world
  169. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  170. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  171. Antimetastatic Therapies according to Metastatic Cascade
  172. Genetics in antidepressant-induced suicide
  173. Pathology of Drug-induced mania & suicide
  174. Influenza treatment
  175. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  176. Individualized cancer chemotherapy
  177. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  178. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  179. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  180. Genomic study of antidepressant-induced suicide
  181. Aberrant sialylation in tumor cells
  182. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  183. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  184. Neural toxicity of drugs
  185. Anticancer activity and mechanisms of Bisdioxopiperazines
  186. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  187. 14C-probimane in the mice bearing LLC
  188. Unsatisfactory design of human AIDS genome research
  189. Antidepressant in Cancer Treatment
  190. AIDS and human genome studies, from a hypothesis to systematic approaches
  191. Antidepressants in Human suicide
  192. Mathematical model in therapeutic risk prediction
  193. Fibrinogen in neoplasm metastasis
  194. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  195. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  196. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  197. Individualized cancer chemotheray
  198. Anti-proliferative and chromosome segregation by probimane and MST-16
  199. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  200. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  201. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  202. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  203. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  204. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  205. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  206. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  207. Journal of Clinical and Medical Reviews